Skip to main content
. 2022 Nov 3;9:951551. doi: 10.3389/fcvm.2022.951551

Figure 1.

Figure 1

From traditional approaches toward precision medicine in cardio-oncology: Implementation of non-routine collected data will generate additional valuable information. AI and machine learning are instrumental for meaningful deep phenotyping of the cardio-oncology patient and lead to more personalized and better CV outcomes.